Related Experiment Video
Updated: Jan 8, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling
Michael S Sturdivant1,2, Andrew S Truong1,2, Mi Zhou1
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract:
The APOBEC3 family of RNA and single stranded DNA cytidine deaminases contribute prominently to the mutagenesis of certain cancers including urothelial carcinoma of the bladder (UC). Remarkably, up to 70% of mutations in UC are attributable to the mutagenic activity of the APOBEC3 deaminases. Despite this strong association, few functional studies have investigated APOBEC3's role in bladder cancer. We report a genetically engineered murine model with conditional knock out of Pten and Trp53 in addition to overexpression of mouse Apobec3 (UPPA). Analysis of bladder tumors from UPPA mice demonstrates that mA3 promotes tumor progression and squamous trans-differentiation. We establish that APOBEC3 promotes squamous differentiation through IL-1α and downstream activation of the AP-1 transcription factor. Bulk RNA-sequencing from human UC shows APOBEC3A as the only human APOBEC3 family member to correlate with squamous differentiation. Furthermore, single cell and spatial transcriptomics reinforces the role of APOBEC3A in fostering squamous trans-differentiation and promoting the emergence of a subpopulation of highly squamous epithelial cells. Our results demonstrate that mouse Apobec3 and human APOBEC3A promote squamous differentiation in urothelial carcinoma and that this trans-differentiation phenotype is mediated through IL-1α signaling, a target of FDA approved therapies for rheumatologic disease.
Insights
APOBEC3 enzymes drive urothelial carcinoma progression and squamous differentiation via IL-1α signaling. This finding highlights APOBEC3A
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The APOBEC3 (A3) family of cytidine deaminases is implicated in mutagenesis across various cancers.
- Urothelial carcinoma of the bladder (UC) exhibits significant mutation burdens attributed to A3 activity, yet its functional role remains understudied.
Purpose of the Study:
- To investigate the functional role of APOBEC3 in bladder cancer progression and squamous differentiation.
- To elucidate the molecular mechanisms by which APOBEC3 influences urothelial carcinoma phenotypes.
Main Methods:
- Development of a genetically engineered murine model (UPPA) with conditional knockout of Pten and Trp53 and overexpression of mouse Apobec3.
- Analysis of bladder tumors from UPPA mice, including bulk RNA-sequencing of human UC samples.
- Application of single-cell and spatial transcriptomics to human UC data.
Main Results:
- Overexpression of mouse Apobec3 in the UPPA model promoted tumor progression and squamous trans-differentiation.
- APOBEC3-driven squamous differentiation was mediated by IL-1α signaling and downstream AP-1 transcription factor activation.
- Human APOBEC3A was identified as the sole APOBEC3 family member correlating with squamous differentiation in UC, confirmed by transcriptomic analyses.
Conclusions:
- Mouse Apobec3 and human APOBEC3A promote squamous differentiation in urothelial carcinoma.
- IL-1α signaling is a key mediator of APOBEC3-induced trans-differentiation in bladder cancer.
- Targeting IL-1α signaling, which is amenable to FDA-approved therapies, may offer a therapeutic strategy for APOBEC3-driven UC.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Hedgehog Signaling Pathway
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

